Punctual Proteins Aid Parasites

A protein’s timely appearance is crucial for Toxoplasma gondii’s unique replication cycle.

Written byLaura Tran, PhD
| 3 min read
Image of Toxoplasma gondii, a parasite, on a colorful background.
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Toxoplasma gondii (T. gondii) infects one in three people at some point during their lifetimes. Immunocompromised and pregnant populations are particularly at risk of side effects or death.1 The parasite replicates, reminiscent of a scene from Alien, through internal budding using an organelle called the inner membrane complex (IMC) to form daughter buds within a mother cell. The IMC scaffold plays a crucial role in replication and recruits most proteins after daughter bud initiation.2 Identifying early arrival proteins in the IMC complex is crucial for guiding the development of antiparasite therapy.

It’s a new chapter in the budding literature of Toxoplasma.
–Marc-Jan Gubbels, Boston College

While scientists know many daughter IMC proteins, most are recruited post bud initiation, leaving the early recruited IMC proteins less understood. This motivated Peter Bradley, a cell biologist at the University of California, Los Angeles, to pinpoint early recruited IMC proteins as potential targets for curbing parasite-related diseases. In a paper published in PLOS Pathogens, Bradley and his team identified a novel IMC protein essential for constructing early daughter buds.3

“The protein scaffold for making daughter buds has a surprising number of redundancies,” said Bradley. “Only some of these earliest daughter proteins are essential.”

See Also "Microplastics in Seawater May Harbor Parasites"

The team conducted a genomic screen and homed in on one protein, IMC43, due to its genetic similarity to IMC32, an early stage protein that Bradley’s team previously identified as essential for replication.4 By staining, they noted that IMC43 arrived at the earliest stage of budding.

Not only was IMC43 punctual, but its absence also contributed to the collapse of the IMC scaffold, resulting in severe morphological defects, and decreasing the viability of the parasite. By looking at IMC43 and IMC32 together, “We figured they’d likely partner with one another,” said Bradley.

Immunofluorescent image of four Toxoplasma gondii parasites with two developing daughter buds inside each cell.
Researchers in the Bradley lab studied the timing of localization for IMC43 (magenta) in comparison to other known daughter markers, such as IMC6 (green).
Rebecca Pasquarelli

Binding assays revealed that the IMC43-IMC32 duo was indeed necessary for daughter bud formation. Another protein the team identified, IMC44, was dispensable in this binding interaction and underscored the importance of IMC43-IMC32’s necessity in replication, structural integrity, and parasite survival.

“This study demonstrates substantial insights into the protein relationships [within the core assembly complex],” said Marc-Jan Gubbels, a cell biologist at Boston College who was not involved in the study. “It’s a new chapter in the budding literature of Toxoplasma.”

Bradley was surprised that the IMC proteins of this replication process were not conserved. The findings suggested that IMC43, unlike IMC32, was specific to T. gondii and no other apicomplexan parasites (for example, Plasmodium).

Intrigued by the differences in core IMC proteins, Bradley plans to identify other important proteins and understand the regulation of these protein-protein interactions to develop vital drugs and vaccines for diseases caused by these parasites.

Related Topics

Meet the Author

  • Laura Tran, PhD

    Laura Tran is an Assistant Editor at The Scientist. She has a background in microbiology. Laura earned her PhD in integrated biomedical sciences from Rush University, studying how circadian rhythms and alcohol impact the gut. While completing her studies, she wrote for the Chicago Council on Science and Technology and participated in ComSciCon Chicago in 2022. In 2023, Laura became a science communication fellow with OMSI, continuing her passion for accessible science storytelling.

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies